Apimeds Pharmaceuticals US, Inc. (APUS) earnings
Quarterly and annual APUS reports and results, each read against the price at its own news timestamp. Back to the APUS overview →
13 measured APUS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Apimeds Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +4.35% | +24.06% | |
| Form 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +6.34% | +0.00% | |
| Form NT 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form NT | +0.00% | -1.32% | |
| Form 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form NT 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form NT | — | -2.23% | |
| Form 10-Q Apimeds Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -1.83% | — | |
| Form 10-Q Apimeds Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.23% | |
| Form NT 10-Q Apimeds Pharmaceuticals For: Jun 30 | SEC filing · Form NT | — | -0.62% | |
| Form 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -1.66% | +2.21% | |
| Form NT 10-Q Apimeds Pharmaceuticals For: Mar 31 | SEC filing · Form NT | +5.23% | -1.16% | |
| Form 10-K/A Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form NT 10-K Apimeds Pharmaceuticals For: Dec 31 | SEC filing · Form NT | — | — |
Keep exploring
More APUS: analyst actions → · SEC filings → · APUS overview →